Try our beta test site

An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study (BIG3)

This study is enrolling participants by invitation only.
Information provided by (Responsible Party):
Region Skane Identifier:
First received: October 25, 2011
Last updated: August 26, 2015
Last verified: August 2015
This is an observational study aiming to identify and validate biomarkers (including imaging and clinical descriptors) for chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD) and lung cancer.

Chronic Obstructive Pulmonary Disease
Cardiovascular Diseases
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: BIG3 - An Open Prospective Longitudinal Pulmonary-cardiovascular Cohort Study

Resource links provided by NLM:

Further study details as provided by Region Skane:

Biospecimen Retention:   Samples With DNA
whole blood, serum

Estimated Enrollment: 10000
Study Start Date: October 2012
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
current daily smokers 100 cigarettes or more during lifetime
current non-smokers


Ages Eligible for Study:   45 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Community sample,residents in Skåne county Sweden.

Inclusion Criteria:

  • 45-75 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01460264

Skåne University Hospital
Lund, Sweden, 221 85
Sponsors and Collaborators
Region Skane
Study Chair: Ulf Malmqvist, MD, PhD Skåne University Hospital
Principal Investigator: David Erlinge, MD, PhD Skåne University Hospital
Principal Investigator: Claes-Göran Löfdahl, MD, PhD Skåne University Hospital
Principal Investigator: Maria Planck, MD, PhD Skåne University Hospital
  More Information

Responsible Party: Region Skane Identifier: NCT01460264     History of Changes
Other Study ID Numbers: BIG3-Region_Skane
Study First Received: October 25, 2011
Last Updated: August 26, 2015

Keywords provided by Region Skane:
Prospective Cohort Study
Respiratory Function Tests
Computed Tomography
Peripheral Arterial Disease

Additional relevant MeSH terms:
Lung Diseases
Cardiovascular Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases processed this record on March 28, 2017